ADMA BIOLOGICS, INC. Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net
ADMA BIOLOGICS, INC. (ADMA) had Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net of $12.60 million as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized · last filed 2020-11-05
- 2020-09-30: Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net $12.60M.
- 2020-06-30: Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net $12.60M.
- 2018-12-31: Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net $12.60M.
| Period end | Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net |
|---|---|
| 2020-09-30 | $12.60M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $12.60M 10-Q · filed 2020-08-05 |
| 2018-12-31 | $12.60M 10-K · filed 2020-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |